Diagnostic and Biotech

2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Hospitals and Commercial Labs

  • VPG22628
  • 585 Pages
  • July 2014
  • Diagnostic and Biotech

Complete report $6,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,350.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.



2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the French cancer diagnostics market during the next five years.  The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.



Rationale



The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next five years, the French cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.



French Market Overview



- Five-year test volume and sales projections.



- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.



- Estimated universe of laboratories performing cancer diagnostic testing.



- Cancer statistics, etiology and recent developments in France.



Business Opportunities and Strategic Recommendations



- Specific new product development opportunities with potentially

significant market appeal during the next five years.



- Design criteria for new products.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



Over 200 Current and Emerging Cancer Diagnostic Test



- Oncogenes

- Biochemical Markers

- Growth Factors

- Colony Stimulating Factors

- Hormones

- Immunohistochemical Stains

- Lymphokines



Supplier Shares, Sales and Volume Forecasts



- Sales and market shares of major cancer diagnostic product

suppliers by individual test.



- Five-year test volume and sales forecasts

for major tumor markers by market segment, including:



     º  Hospitals

     º  Commercial/Private Laboratories



Instrumentation Review



- Analysis of major molecular diagnostic and immunodignostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.



Technology Assessment



- Assessment of latest technologies

and their potential applications for cancer diagnostic testing.



- Review of competing/complementing technologies.



- Extensive listings of companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.



Competitive Strategies



- Strategic assessments of major suppliers

and start-up firms developing innovative cancer diagnostic

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.



- The companies analyzed in the report include:



   - Abbott

   - AdnaGen

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca/Nuvelo

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomedical Diagnostics

   - bioMerieux

   - Bio-Rad

   - CellSearch

   - Cepheid

   - Correlogic Systems/Vermillion

   - Decode

   - Diadexus

   - Diagnocure

   - DiaSorin

   - Eiken Chemical

   - Epigenomics

   - Enterix

   - Enzo Biochem

   - Exact Sciences

   - Fujirebio/Innogenetics

   - Guided Therapeutics

   - Hologic/Gen-Probe

   - Kreatech

   - Kyowa Medex

   - Mackay Life Sciences

   - Myriad Genetics

   - Nanogen Elitech

   - OncoLab

   - Ortho-Clinical Diagnostics

   - Panacea Pharmaceuticals

   - Polartechnics

   - Polymedco

   - PreMD

   - Qiagen/Ipsogen

   - Quest Diagnostics

   - Radient Pharmaceuticals

   - Roche

   - Scienion

   - Sequenom

   - Siemens Healthcare

   - Takara Bio

   - Targeted Diagnostics & Therapeutics

   - Thermo Fisher/Life Technologies

   - Tosoh

   - Veridex

   - Wako Pure Chemicals

   - Wallac/PE

   - Zilla



Contains 585 pages and 85 tables


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Genotyping Market - Opportunities and Forecasts, 2015 - 2020

Genotyping is the process of studying DNA sequence to determine genetic constitution in the genotypes of living organisms, such as humans, plants, animals, and microorganisms. Human genotyping helps in determining ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Plasma Fractionation Market - Opportunities and Forecasts, 2015 - 2020

Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global C-Reactive Protein Testing Market (Application, Types of Assays and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Digital Polymerase Chain Reaction (dPCR) Market (Technology, Type, Application, End User and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Digital Polymerase Chain Reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Live Cell Imaging Market - Opportunities and Forecast, 2014 - 2020

Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>